Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Common Equity (2018 - 2025)

Zai Lab (ZLAB) has disclosed Common Equity for 8 consecutive years, with $715.5 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 14.91% to $715.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $715.5 million through Dec 2025, down 14.91% year-over-year, with the annual reading at $715.5 million for FY2025, 14.91% down from the prior year.
  • Common Equity hit $715.5 million in Q4 2025 for Zai Lab, down from $759.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.7 billion in Q2 2021 to a low of $667.7 million in Q3 2024.
  • Historically, Common Equity has averaged $999.2 million across 5 years, with a median of $906.6 million in 2023.
  • Biggest five-year swings in Common Equity: skyrocketed 259.15% in 2021 and later plummeted 30.36% in 2022.
  • Year by year, Common Equity stood at $1.4 billion in 2021, then decreased by 24.23% to $1.0 billion in 2022, then fell by 23.86% to $796.1 million in 2023, then grew by 5.62% to $840.9 million in 2024, then fell by 14.91% to $715.5 million in 2025.
  • Business Quant data shows Common Equity for ZLAB at $715.5 million in Q4 2025, $759.9 million in Q3 2025, and $791.7 million in Q2 2025.